Tag: TROPHY

Home / TROPHY

Categories

Sacituzumab govitecan receives fast approval from the FDA for advanced urothelial cancer

August 2021: Sacituzumab govitecan (Trodelvy, Immunomedics Inc.) was given accelerated approval by the Food and Drug Administration for patients with locally advanced or metastatic urothelial cancer (...
trophy

Scan the code